
Results
2
Stocks where the price continues to rise after more than a year of consistent gains.
2 companies
Lin BioScience
Market Cap: NT$36.6b
A drug development company, develops therapies for oncology, ophthalmology, and metabolic diseases.
6696
NT$442.50
7D
50.8%
1Y
206.2%
AP Biosciences
Market Cap: NT$11.4b
Researches and develops protein and antibody drugs for unmet medical needs.
6945
NT$133.50
7D
25.4%
1Y
164.4%